A. K. Kakkar

Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

Bengt I. Eriksson, Lars C. Borris, O.E. Dahl et al. · Journal of Thrombosis and Haemostasis · 2005 · 300 citations · Full text

Medicine, Orthopedic Surgery, Pharmacology +17

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

C. W. Francis, Craig M. Kessler, Samuel Z. Goldhaber et al. · Journal of Thrombosis and Haemostasis · 2015 · 241 citations · Full text

Medicine, Oncology, Pharmacology +16

The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry

Manuel Monréal, A. K. Kakkar, Joseph A. Caprini et al. · Journal of Thrombosis and Haemostasis · 2004 · 182 citations · Full text

Medicine, Hematology, Surgery +12

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

Bengt I. Eriksson, A. K. Kakkar, Alexander G.G. Turpie et al. · Journal of Bone and Joint Surgery - British Volume · 2009 · 181 citations

Medicine, Pharmacology, Pharmacotherapy +17

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease

Deepak L. Bhatt, John W. Eikelboom, Stuart J. Connolly et al. · Circulation · 2020 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17